Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation

Vandebriel, RJStalpers, CALVermeulen, JPRemkes, MSchmelter, MBroere, FHoefnagel, MHN2025-03-312025-03-3120223599907810.1016/j.vaccine.2022.08.022https://rivm.openrepository.com/handle/10029/653825Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activationArticleVaccine 2022; 40(38):5601-56072025-03-31